Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC–MS/MS analysis
Ming Yao(Chinese Preventive Medicine Association), Renke Dai(Bristol-Myers Squibb (Germany)), Mingshe Zhu(Ocean Power Technologies (United States)), A. David Rodrigues(Bristol-Myers Squibb (Germany)), W. Griffith Humphreys(Bristol-Myers Squibb (United States)), Hongjian Zhang(Bristol-Myers Squibb (Germany)), Michael Sinz(Rutgers, The State University of New Jersey)
Cited by 67
Related Papers
CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes
|Drug Metabolism and Disposition|2002|447
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
|Chemical Research in Toxicology|1998|312
Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole
|Oncogene|2006|211
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)
|Antimicrobial Agents and Chemotherapy|2012|186
Pharmacokinetic Drug Interactions Involving 17??-Ethinylestradiol
|Clinical Pharmacokinetics|2007|174